Not applicableStudy completedNCT00743054What this trial is testingMicroRNA Expression in Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Sun Yat-sen University 50
Not applicableStudy completedNCT00895674What this trial is testingPatient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With NexavarWho this might be right forCarcinoma, Renal CellCarcinoma, Renal Cell (Advanced) Bayer 2,840
Testing effectiveness (Phase 2)Study completedNCT00445042What this trial is testingSafety and Toxicity Study of Sorafenib in Patients With Kidney CancerWho this might be right forCarcinoma, Renal Cell The Methodist Hospital Research Institute 71
Early research (Phase 1)Study completedNCT02890069What this trial is testingPDR001 in Combination With LCL161, Everolimus or PanobinostatWho this might be right forColorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Novartis Pharmaceuticals 298
Testing effectiveness (Phase 2)Looking for participantsNCT03972657What this trial is testingA Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsWho this might be right forMetastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC) Regeneron Pharmaceuticals 345
Testing effectiveness (Phase 2)UnknownNCT03544723What this trial is testingSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Who this might be right forSolid TumorLymphoma MultiVir, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT03945773What this trial is testingStudy of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint InhibitorsWho this might be right forLocally Advanced or Metastatic Renal Cell Carcinoma Ipsen 127
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT01689766What this trial is testingStudy Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Endocyte 150
Early research (Phase 1)Active Not RecruitingNCT05614102What this trial is testingA First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bayer 284
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07101900What this trial is testing68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT03991130What this trial is testingHigh Dose IL-2 in Combination With Anti-PD-1Who this might be right forMelanomaRenal Cell Carcinoma, Metastatic Gregory Daniels 6
Large-scale testing (Phase 3)Study completedNCT03138512What this trial is testingA Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a KidneyWho this might be right forCarcinoma, Renal Cell Bristol-Myers Squibb 1,641
Early research (Phase 1)Study completedNCT02498665What this trial is testingDSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesGlioblastoma Multiforme+6 more Sumitomo Pharma America, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT01793636What this trial is testingA Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal CancerWho this might be right forMetastatic Clear Cell Renal Carcinoma Queen Mary University of London 49
Testing effectiveness (Phase 2)Study completedNCT00278395What this trial is testingVorinostat in Treating Patients With Kidney CancerWho this might be right forRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00782275What this trial is testingAvastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaKidney Cancer Beth Israel Deaconess Medical Center 41
Very early researchStudy completedNCT00884520What this trial is testingAn Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037Who this might be right forLung CancerSquamous Cell CarcinomaHead and Neck Cancer+2 more Siemens Molecular Imaging 16
Testing effectiveness (Phase 2)Study completedNCT04090710What this trial is testingSBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney CancerWho this might be right forMetastatic Renal Cell Carcinoma Ontario Clinical Oncology Group (OCOG) 66